Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO <i>resect</i> group

Abstract

The proposed "RANO categories for extent of resection in glioblastoma" are highly prognostic and may serve for stratification within clinical trials. Removal of non-CE tumor beyond the CE tumor borders may translate into additional survival benefit, providing a rationale to explicitly denominate such "supramaximal CE resection."